Literature DB >> 21401740

Genotyping of Malassezia pachydermatis isolates from canine healthy skin and atopic dermatitis by internal spacer 1 (IGS1) region analysis.

Tetsuya Kobayashi1, Rui Kano, Masahiko Nagata, Atsuhiko Hasegawa, Hiroshi Kamata.   

Abstract

Isolates of Malassezia pachydermatis from healthy dog skin and from dogs with atopic dermatitis were molecularly characterized using internal spacer 1 (IGS1) region analyses, and their phospholipase A2 activity and pH growth profiles were then characterized in vitro. The percentage of isolates from healthy dogs that had the following IGS1 subtypes (isotype, %) were as follows: 1A, 6%; 1B, 27%; 1C, 11%; 2A, 6%; 2B, 6%; 3A, 11%; 3C, 3%; and 3D, 24%. In contrast, 9% of isolates from dogs with atopic dermatitis were isotype IB and 91% were isotype 3D, indicating that isolates of subtype 3D were the most prevalent in dogs with atopic dermatitis. Production of phospholipase A2 was statistically higher in isolates of subtype 3D than in the other subtypes. The subtype 3D isolates showed enhanced growth on alkaline medium compared with non-3D subtype isolates. The main clinical sign of canine Malassezia dermatitis is waxy exudates on the skin, which predispose the patient to development of a yeast overgrowth of the subtype 3D. Increased phospholipase A2 production may be involved in the inflammatory process associated with Malassezia dermatitis.
© 2011 The Authors. Veterinary Dermatology. © 2011 ESVD and ACVD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21401740     DOI: 10.1111/j.1365-3164.2011.00961.x

Source DB:  PubMed          Journal:  Vet Dermatol        ISSN: 0959-4493            Impact factor:   1.589


  6 in total

1.  Cryptic Diversity of Malassezia pachydermatis from Healthy and Diseased Domestic Animals.

Authors:  Laura Puig; Gemma Castellá; F Javier Cabañes
Journal:  Mycopathologia       Date:  2016-06-09       Impact factor: 2.574

2.  Genotyping and characterisation of the secretory lipolytic enzymes of Malassezia pachydermatis isolates collected from dogs.

Authors:  Hideshi Teramoto; Yuko Kumeda; Kumio Yokoigawa; Koji Hosomi; Shunji Kozaki; Masafumi Mukamoto; Tomoko Kohda
Journal:  Vet Rec Open       Date:  2015-08-21

3.  In vitro susceptibility of Malassezia pachydermatis isolates from canine skin with atopic dermatitis to ketoconazole and itraconazole in East Asia.

Authors:  Shion Watanabe; Anna Koike; Rui Kano; Masahiko Nagata; Charles Chen; Cheol-Yong Hwang; Atsuhiko Hasegawa; Hiroshi Kamata
Journal:  J Vet Med Sci       Date:  2013-12-13       Impact factor: 1.267

Review 4.  Malassezia infections in humans and animals: pathophysiology, detection, and treatment.

Authors:  Aristea Velegraki; Claudia Cafarchia; Georgios Gaitanis; Roberta Iatta; Teun Boekhout
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

Review 5.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

Review 6.  Malassezia spp. Yeasts of Emerging Concern in Fungemia.

Authors:  Wafa Rhimi; Bart Theelen; Teun Boekhout; Domenico Otranto; Claudia Cafarchia
Journal:  Front Cell Infect Microbiol       Date:  2020-07-28       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.